Mechanical Thrombectomy of an Obstructive Mechanical Mitral Valve Thrombus Using the FlowTriever Device With Embolic Protection: A Case Report Authors: Asad Rizvi, Shane Metzler, Amir Malik, Farhan Ali Published: 2026 ABSTRACT AbstractManagement of obstructive mechanical mitral valve thrombosis in patients with prohibitive surgical risk and contraindication to thrombolytics is not well defined. Transcatheter approaches, such as manipulation of immobile valve leaflets and aspiration of the obstructive thrombus using various devices, have been successfully attempted. We report the first case of mechanical thrombectomy of an obstructive mechanical mitral valve thrombosis using the FlowTriever system. Future research should focus on developing comprehensive embolic protection strategies and larger studies to establish the safety, efficacy, and indications of this procedure.Keywords: case report, left atrial mass, mechanical mitral valve, mechanical thrombectomy, thrombus Case Presentation A 50-year-old woman with past medical history of severe mitral regurgitation status post mechanical valve replacement in 2023, anomalous left coronary artery from the pulmonary artery status post surgical ligation and bypass, and cerebrovascular accident with hemorrhagic conversion presented with a complaint of shortness of breath. She was found to have pulmonary edema and cardiogenic shock requiring mechanical ventilation and pressor support. A transesophageal echocardiogram (TEE) showed a large thrombus on the mechanical mitral valve with restricted leaflet motion. She had a known history of nonobstructive mechanical mitral valve thrombus diagnosed a year ago, which was being treated with warfarin and aspirin 81 mg daily, and a posterior left middle cerebral artery territory infarct with hemorrhage. International normalized ratio was subtherapeutic (1.1) on admission, and the patient endorsed adherence to warfarin. A heparin drip was started on admission. Heart team evaluation deemed her high risk for surgery due to 2 previous sternotomies and was not a candidate for thrombolytics due to a previous stroke and hemorrhage. After a risk-benefit discussion with the patient, we proceeded with the mechanical thrombectomy procedure. Intraprocedural TEE showed a large thrombus on the mechanical mitral valve with restricted leaflet motion (Figure 1A, 1B, Supplemental Video 1). The mean gradient was 16 mm Hg, consistent with severe stenosis of the mechanical mitral valve (Figure 2A). Incidentally, a right atrial (RA) thrombus was noted, raising the possibility of a paradoxical embolus; however, a TEE with bubble study performed 8 months before the procedure was negative for patent foramen ovale or inter-atrial shunt. A lower extremity venous ultrasound performed the day after the procedure was negative for deep vein thrombosis. The RA thrombus was likely due to a Swan-Ganz catheter, which was removed before the procedure. Mechanical mitral valve thrombus pre and post thrombectomy.(A) Intra-procedural TEE mid-esophageal view at 90° showing the thrombus (arrow) on the mechanical mitral valve before thrombectomy. (B) 3D echocardiogram view of the thrombus on the mechanical mitral valve before thrombectomy. (C) TEE mid-esophageal view showing no thrombus on the mechanical mitral valve after thrombectomy. (D) 3D echocardiogram view showing no thrombus on the mechanical mitral valve after thrombectomy. Doppler interrogation of the mechanical mitral valve.(A) Continuous-wave (CW) Doppler showing mean diastolic mitral valve gradient of 16.19 mm Hg before thrombectomy. (B) CW Doppler showing mean diastolic mitral valve gradient of 3.25 mm Hg after thrombectomy. (C) Aspirated thrombus fragments. Vascular access was obtained from the right radial artery, and a cerebral embolic protection device was placed in the proximal left common carotid artery and the right innominate artery. Vascular access was then obtained from the right femoral vein, and a transseptal puncture was made under fluoroscopic and TEE guidance. A balloon septostomy of the interatrial septum was performed using a 14 mm × 40 mm balloon inflated to 6 atm to facilitate sheath delivery. A 24F sheath was inserted, and the FlowTriever 20 curve device (Inari) was then delivered and placed in the left atrium (Figure 3A, 3B). Mechanical thrombectomy was initiated, and after 6 attempts, the thrombus was successfully aspirated through the catheter and sent for analysis (Supplemental Video 2, Figure 2C). The FlowSaver system was used to return the aspirated blood to the patient, who remained hemodynamically stable. Placement of the FlowTriever device.(A) TEE image showing the FlowTriever catheter going through the transeptal puncture in the left atrium. (B) FlowTriever catheter in the left atrium under fluoroscopy. No residual thrombus was noted on the mitral valve and in the left atrium postthrombectomy (Figure 1C, 1D, Supplemental Video 3). The valve movement was completely normalized, and the mean gradient decreased to 3 mm Hg (Supplemental Video 3, Figure 2B). The FlowTriever catheter was pulled back in the right atrium, and the right atrial thrombus was aspirated. A small residual septal defect with mild left-to-right shunting was noted. The sheath was removed, and hemostasis was obtained using a closure device. The cerebral embolic protection device was retrieved, and no evidence of embolic material was noted on inspection. Pathology confirmed fibrin thrombus. The patient’s cardiac symptoms resolved, but she developed left-sided weakness the day after the procedure, and head imaging confirmed a small right middle cerebral artery territory ischemic stroke. Her neurological symptoms resolved completely over the following days. Anticoagulation with LMWH to warfarin bridge was re-initiated, and the patient was discharged when international normalized ratio was therapeutic with a higher target of 3.5. Discussion Treatment options for obstructive mechanical mitral valve thrombosis include optimizing anticoagulation, thrombolysis, surgery, and transcatheter manipulation.1 The European Society of Cardiology gives a class I recommendation for surgery in critically ill patients without serious comorbidities and thrombolysis in patients who are high risk for surgery or when surgery is not available.2 In contrast, the ACC/AHA gives a class I recommendation for either low-dose, slow infusion of thrombolytics or surgery, depending on local clinical and surgical experience.3 There is limited guidance on the management of patients who are high risk for surgery and have contraindications to thrombolysis, as was the case for our patient.3 Transcatheter manipulation of immobile mechanical mitral valve leaflets has been performed successfully in patients who fail thrombolysis or are at high risk for surgery.1,4 However, this approach does not offer a way to completely aspirate the thrombus, particularly in cases of high thrombus burden. Transcatheter aspiration of left-sided masses has been gaining popularity recently, with most cases involving vegetations, left atrial thrombi, or thrombi on bioprosthetic mitral valves. Moreover, the AngioVac system is the most cited device used for aspirating left-sided masses.5 The literature reports 2 cases of transcatheter aspiration of mechanical mitral valve thrombi; one using the AngioVac system and the other using the Penumbra Lightning 12.6,7 To our knowledge, ours is the first published case using the FlowTriever device for this indication. Our decision to use the FlowTriever system was based on the potential advantages of a larger bore for more efficient aspiration compared with the Penumbra and less instrumentation, setup, and cost compared with the AngioVac system. The FlowTriever device has also been successfully used to aspirate left-sided vegetations and thrombus on bioprosthetic mitral valves.8 Embolization of thrombi is a major limitation of this procedure, as in our case, the patient developed ischemic stroke postprocedure. Cerebral protection is commonly achieved using a specific device to protect the right and left internal carotid arteries, but the vertebral artery and systemic circulation remain exposed. Innovative approaches, such as using an additional device to protect the vertebral artery, using a specialized left atrial appendage occluder device in the ascending aorta, and using a specialized device for complete systemic protection, have been successfully attempted.5,9 Conclusion Mechanical thrombectomy using the FlowTriever device is a viable alternative for patients with obstructive mechanical mitral valve thrombosis at prohibitive surgical risk and thrombolysis contraindications. Embolization risk highlights the need for comprehensive protection strategies. Finally, larger studies are needed to define the safety, efficacy, and indications of this approach. CRediT authorship contribution statement Asad Rizvi: Writing – original draft. Shane Metzler: Writing – review & editing. Amir Malik: Writing – review & editing, Supervision, Conceptualization. Farhan Ali: Writing – review & editing, Supervision, Conceptualization. Acknowledgments Declaration of competing interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding sources This research was supported (in whole or in part) by HCA Healthcare and/or an HCA Healthcare-affiliated entity. The views expressed in this publication represent those of the authors and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities. Ethics statement and patient consent Research for this case report was conducted in accordance with the relevant ethical guidelines. Written informed consent was obtained from the patient for publication of this work. Footnotes To access the supplementary material accompanying this article, visit the online version of the Journal of the Society for Cardiovascular Angiography & Interventions at 10.1016/j.jscai.2026.105459. Supplementary material Supplemental Video 1 3D echocardiography of mechanical mitral valve with thrombus. Supplemental Video 2 TEE view of the thrombus being aspirated with the FlowTriever device. Supplemental Video 3 3D echocardiography of mechanical mitral valve postthrombectomy showing normal leaflet motion. References Associated Data Supplementary Materials Supplemental Video 1 3D echocardiography of mechanical mitral valve with thrombus. Supplemental Video 2 TEE view of the thrombus being aspirated with the FlowTriever device. Supplemental Video 3 3D echocardiography of mechanical mitral valve postthrombectomy showing normal leaflet motion.